Massive Bio Announces Partnership With Patient-Centered Group Self Care Catalysts and Veterans Prostate Cancer Awareness Non-Profit to Improve Clinical Trial Diversity and Oncology RWE

September 1, 2021

Massive Bio will partner with non-profit group Veterans Prostate Cancer Awareness (VPCa) and patient-centered organization Self-Care Catalysts to promote enrollment in clinical trials and in real world evidence (RWE) studies. Massive Bio provides extensive experience in clinical trial enrollment using artificial intelligence while VPCa promotes prostate cancer awareness and advances treatments. Self-Care Catalysts uses its Health Storylines platform to improve patient centricity in real world data (RWD) collection used to inform healthcare decision-makers.

Founder and CEO of Self Care Catalysts Grace Castillo-Soyao remarks, “Our partnership with Veterans Prostate Cancer Awareness and Massive Bio brings together an unprecedented platform to drive real-world evidence research and outcome.” Read more here.

(Source: Business Wire, 8/31/21)

Share This Story!